cell therapy
therapeutic cells
gene therapy approach
concept
steps
cell implantation
novel ex
prepared cell
safety profile
culture of cells
gene lead
automation of cell expansion
manipulation of patient cells
implantable therapeutic device
safety studies
genetic deficiency
genetic defect
tools
proof
HemAcure project
targeted delivery of therapeutic Factor
correct genetic copy of FVIII
Application of combined gene
European GMP-regulations
appropriate haemophilia
clotting factor
product’s efficacy
European authorities
product’s manufacturability
production cost
treatment of severe hemophilia
bleeding disease haemophilia
FP7 ReLiver project
improved quality of life
worldwide unique medical device
mutations
main objective
patients’ blood
passage
design
functionality
respect
animal models
important goals
process
requirements
isolation
systematic way
technologies
risks
clear understanding
Medicyte
scalable bioreactor
refinement
work program
beginning
development
aim